E- QURE CORPORATION (OTCMKTS:EQUR) Can’t Be Less Risky. Short Interest Decreased

September 13, 2017 - By Ellis Scott

The stock of E- QURE CORPORATION (OTCMKTS:EQUR) registered a decrease of 55.56% in short interest. EQUR’s total short interest was 400 shares in September as published by FINRA. Its down 55.56% from 900 shares, reported previously. With 100 shares average volume, it will take short sellers 4 days to cover their EQUR’s short positions.

It closed at $0.085 lastly. It is down 0.00% since September 13, 2016 and is . It has underperformed by 16.70% the S&P500.

E-Qure Corp. owns intellectual property of technology of wound healing device. The company has market cap of $1.89 million. The IP assets, including the wound healing device, are designed for wound treatment incorporating Bioelectrical Signal Therapy (BST Device). It currently has negative earnings. The BST Device implements electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure.

More notable recent E-QURE Corp (OTCMKTS:EQUR) news were published by: Finance.Yahoo.com which released: “EQUR: Healing Chronic Wounds With Electrical Stimulation” on January 09, 2017, also Prnewswire.com with their article: “FDA Granted E-QURE Approval to Initiate Its US Clinical Trial” published on November 02, 2016, Prnewswire.com published: “E-QURE’s BST Device for Chronic Wound Care Receives Marketing Approval in Israel” on February 24, 2017. More interesting news about E-QURE Corp (OTCMKTS:EQUR) were released by: Prnewswire.com and their article: “E-QURE Signs Distribution Agreement for its Breakthrough Wound Care Device for …” published on January 18, 2017 as well as Seekingalpha.com‘s news article titled: “E-Qure: Wound Healing With Electrical Stimulation” with publication date: February 03, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.